Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures [Corrigendum]
Patel RR, Liang SY, Koolwal P, Kuhlmann FM. Therapeutics and Clinical Risk Management. 2015;11:217–228.
On page 224, Meningococcal vaccine heading, second sentence “Vaccination is recommended with the quadrivalent polysaccharide (Menactra™)” should have read “Vaccination with the quadrivalent meningococcal conjugate vaccine (MCV4) is recommended”.
Read the original paper
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.